• Globe Newswire

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

Globenewswire -

• Globe Newswire

Io Therapeutics, Inc. announces publication in Scientific Reports – Nature, of studies showing synergistic efficacy of its RXR agonist IRX4204 with the standard of care drug lenalidomide against multiple myeloma.

Globenewswire -

• Globe Newswire

Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.

Globenewswire -

• Globe Newswire

DEBx Medical Secures Expanded Investment from TVM Capital Healthcare

Globenewswire -

• Globe Newswire

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition

• Globe Newswire

CORRECTION: The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners

• Globe Newswire

The Global Virus Network Bolsters Multinational Mpox Response Through Critical Meeting of Key Global Partners